The Mesowatch Blog is designed to inform and empower victims of asbestos exposure. We cover recent news, lawsuits, trust claims, data reports and medical research involving asbestos-related lung cancer or mesothelioma caused by corporate negligence in the U.S. We are the leading resource for victims of asbestos-related illnesses looking for legal advice and analysis on landmark asbestos cases.
Cancer is the deadliest disease of all, no matter what type of malignancy it is. Only in 2018, about 9.6 million people have died due to cancer worldwide. Though the cancer death rate has decreased by 27% in the US in the last 25 years, still new stats are not...
read more
Early detection of mesothelioma or any other cancer is the crucial factor for increasing life expectancy. Recently published results of a long-term study say that low-dose computed tomography screening can improve the life expectancy of pleural mesothelioma for more...
read more
A Philadelphia based company, Iovance Biotherapeutics Inc. is working on new T-cell therapy to treat advanced metastatic cancers. The new immunotherapy uses specific lymphocytes from the patient’s immune system called tumor-infiltrating lymphocytes. TIL or...
read more
In a multicenter clinical trial, the positive effect of the novel MesoPher vaccine is observed. With this vaccine, the patient's immune system will be able to recognize and fight the mesothelioma tumor cells. Thus, it will halt the tumor from coming back after initial...
read more
Researchers identified a specific protein, IDH1, within the High-grade serous ovarian cancer cells that promote the proliferation of these cancer cells. Targeting this protein with drugs can help halt the spread of ovarian cancer. High-grade serous ovarian cancer...
read more
Newly diagnosed ovarian cancer patients can now have access to cancer delaying drug, Olaparib. Before this, only advanced ovarian cancer patients take Olaparib in later stages of treatment. NICE, The National Institute for Health and Care Excellence approved the use...
read more
Discovering the cure for malignant mesothelioma is very important. And doctors are using radical approaches in the currently approved radiotherapy, chemotherapy, and surgical treatments. Simultaneously, finding the mechanism with which tumor cells progress and...
read more
A recent oncology study has shown that delivering Oxaliplatin through a new spray-on technique may increase in the survival of advanced peritoneal mesothelioma with few side effects. Oncologists from France, Saudi Arabia, and Switzerland studied the effectiveness of...
read more
A federal judge will rule next week on what evidence will be admitted in ongoing lawsuits against Johnson & Johnson (J&J) alleging that asbestos in the company’s talc-based products has caused ovarian cancer and mesothelioma. The outcome of the hearing in a...
read more
Chemotherapy with Niraparib can extend the life of ovarian cancer patients who have already undergone 4 or more chemotherapy treatments. American researchers give hope to ovarian cancer patients who have undergone several rounds of chemotherapy treatment and have lost...
read more